Join the Search. Be a Hero.
The Resilience Project launched in 2014 with a unique vision by Stephen Friend and Eric Schadt that by studying massive numbers of healthy adults, scientists might find rare individuals who are unaffected by genetic variants that should induce disease. Genome analysis of these resilient people could uncover naturally occurring, protective mechanisms that would serve as novel treatments for people affected by these diseases.
April 11, 2016 the first finding from the project were published in Nature Biotechnology, Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases. Publication Press Release
Nature Press Conference
For more information about the Nature Biotechnology publication, listen to the press briefing led by Stephen Friend, President of Sage Bionetworks.
Interested in “Genetic Heroes”?
Stephen Friend shares papers and talks that illuminate this exciting new approach: Learn More
- New York Times, People Who Avoided Illness Could Be Key in Treating Those Who Didn’t
- NPR All Things Considered, How Do ‘Genetic Superheroes Overcome Their Bad DNA
- BBC News, ‘Superhero DNA’ Keeps Diseases at Bay
- PBS, These 13 Adults Escaped Deadly Genetic Childhood Disorders, But How?
- Science Magazine, ‘Buffer Genes’ May Protect These 13 People from Rare Genetic Diseases
- The Economist, Genetic Superheroes
- The Atlantic, Thirteen Anonymous Genetic Superheroes Walk Among Us
- Wired, Genetic Superheroes Walk Among Us, But Shhh! No One Can Tell ‘Em
- MIT Technology Review, Search for New Medical Treatments Zeroes in on Genetic Superheroes
- New Scientist, The Genetic Superheroes Who Have Mutations But Not the Disease
- The Guardian, Scientists Search for 13 People to Solve Genetic Mutation Mystery
- The Independent, ‘Genetic Superheroes’ Are Real and Could Lead to Life-Saving Treatments – But Nobody Can Talk to Them
- The Mirror, Genetic Superheroes Could Bring Life-Saving Treatment to Millions
- Stat, Genetic ‘Unicorns’ Defy Their Own DNA – And Could Hint at New Treatments